Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421315 · ClinicalTrials.gov registry record · NA
Overlapping Neural Circuits in Pediatric OCD
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT02421315 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 55 participants.
The verdict
NCT02421315, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the brain functioning of children and adolescent with OCD before and after treatment with Exposure and Response Prevention (EXRP) therapy.
Interventions
- BEHAVIORAL CBT treatment for OCD based on Exposure & Response Prevention (EX/RP) and when indicated medication treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2014-10 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02421315
The ClinicalTrials.gov registry entry for NCT02421315 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CBT treatment for OCD based on Exposure & Response Prevention (EX/RP) and when indicated medication treatment is the first listed.
NCT02421315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02421315 about?
NCT02421315 is a clinical study titled "Overlapping Neural Circuits in Pediatric OCD". The purpose of this study is to examine the brain functioning of children and adolescent with OCD before and after treatment with Exposure and Response Prevention (EXRP) therapy.
What is the current status of trial NCT02421315?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2014-10. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT02421315?
The interventions under investigation include: CBT treatment for OCD based on Exposure & Response Prevention (EX/RP) and when indicated medication treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02421315?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.